These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18692698)

  • 21. FDA to require bar coding of most pharmaceuticals by mid-2006.
    Traynor K
    Am J Health Syst Pharm; 2004 Apr; 61(7):644-5. PubMed ID: 15119567
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-39. PubMed ID: 21374841
    [No Abstract]   [Full Text] [Related]  

  • 23. Judge strikes down FDA policies on industry dissemination of off-label information.
    Miller JL
    Am J Health Syst Pharm; 1999 Sep; 56(17):1695-6. PubMed ID: 10512492
    [No Abstract]   [Full Text] [Related]  

  • 24. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):739-40. PubMed ID: 27208054
    [No Abstract]   [Full Text] [Related]  

  • 25. Supreme Court rules that FDA cannot regulate tobacco industry.
    Gottleib S
    BMJ; 2000 Apr; 320(7239):894. PubMed ID: 10787253
    [No Abstract]   [Full Text] [Related]  

  • 26. Commissioner Kessler's agbio legacy.
    Hoyle R
    Nat Biotechnol; 1997 Jan; 15(1):2. PubMed ID: 9035091
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA regulatory compliance reconsidered.
    Tobias C
    Cornell Law Rev; 2008 Jul; 93(5):1003-38. PubMed ID: 18618969
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA and the 1997 Tobacco Settlement: no rules for twelve years?
    O'Reilly JT
    Food Drug Law J; 1997; 52(3):253-8. PubMed ID: 10343024
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449
    [No Abstract]   [Full Text] [Related]  

  • 30. Trying times for generic medicines in the USA.
    Lancet; 2013 Mar; 381(9872):1072. PubMed ID: 23540840
    [No Abstract]   [Full Text] [Related]  

  • 31. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):e375-7. PubMed ID: 27208062
    [No Abstract]   [Full Text] [Related]  

  • 32. Summaries of safety labeling changes approved by FDA-Boxed Warnings Highlights October-December 2014.
    Rubio T
    Am J Health Syst Pharm; 2015 Mar; 72(5):343. PubMed ID: 25694404
    [No Abstract]   [Full Text] [Related]  

  • 33. Off-label drug use.
    Dooley AG
    Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA eases medication guide distribution requirements.
    Traynor K
    Am J Health Syst Pharm; 2011 Apr; 68(8):649-50. PubMed ID: 21460167
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA narrows drug label usage.
    Dolgin E
    Nature; 2009 Aug; 460(7259):1069. PubMed ID: 19713906
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA requires boxed warning for all immediate-release opioid products.
    Thompson CA
    Am J Health Syst Pharm; 2016 May; 73(9):e114-5. PubMed ID: 27099322
    [No Abstract]   [Full Text] [Related]  

  • 37. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC
    Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract]   [Full Text] [Related]  

  • 38. Off-label prescribing. Legal implications.
    Henry V
    J Leg Med; 1999 Sep; 20(3):365-83. PubMed ID: 10530051
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA legislation.
    Myers M
    Tob Control; 2007 Oct; 16(5):289-90. PubMed ID: 17897976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A much-anticipated FDA reform bill is signed into law: progress and compromise.
    Nissen SE
    Curr Cardiol Rep; 2008 Feb; 10(1):1-2. PubMed ID: 18416992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.